3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
23 24 0 0 0 0 0 0 0999 V2000
3.0075 -1.3786 -0.0658 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.7311 0.6196 -0.0220 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4754 1.2227 0.0531 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1475 -2.1153 0.4214 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2702 -1.9841 -0.1164 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0624 -1.1203 -0.2682 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7708 -0.5652 -0.0336 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1041 0.5374 -0.0133 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5759 0.2993 -0.0555 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1570 -0.3425 -0.0236 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4200 1.8361 0.0363 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6692 0.9521 0.0280 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8014 2.0387 0.0595 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5095 -3.1369 0.2594 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.1525 -1.9356 1.5045 H 0 0 0 0 0 0 0 0 0 0 0 0
0.3068 -2.3067 -1.1641 H 0 0 0 0 0 0 0 0 0 0 0 0
0.9234 -2.6497 0.4604 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.0525 -1.3314 0.1439 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.1049 -1.3090 -1.3478 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.2363 2.7023 0.0537 H 0 0 0 0 0 0 0 0 0 0 0 0
3.7432 1.1119 0.0394 H 0 0 0 0 0 0 0 0 0 0 0 0
2.1989 3.0489 0.0975 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.3222 1.3860 0.0687 H 0 0 0 0 0 0 0 0 0 0 0 0
1 10 1 0 0 0 0
2 3 1 0 0 0 0
2 23 1 0 0 0 0
3 9 2 0 0 0 0
4 5 1 0 0 0 0
4 6 1 0 0 0 0
4 14 1 0 0 0 0
4 15 1 0 0 0 0
5 7 1 0 0 0 0
5 16 1 0 0 0 0
5 17 1 0 0 0 0
6 9 1 0 0 0 0
6 18 1 0 0 0 0
6 19 1 0 0 0 0
7 8 2 0 0 0 0
7 10 1 0 0 0 0
8 9 1 0 0 0 0
8 11 1 0 0 0 0
10 12 2 0 0 0 0
11 13 2 0 0 0 0
11 20 1 0 0 0 0
12 13 1 0 0 0 0
12 21 1 0 0 0 0
13 22 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
(NE)-N-(5-fluoro-3,4-dihydro-2H-naphthalen-1-ylidene)hydroxylamine
4.2 InChl
InChI=1S/C10H10FNO/c11-9-5-1-4-8-7(9)3-2-6-10(8)12-13/h1,4-5,13H,2-3,6H2/b12-10+
4.3 InChlKey
ULDTWMIGAQGOHG-ZRDIBKRKSA-N
4.4 Canonical SMILES
C1CC2=C(C=CC=C2F)C(=NO)C1
4.5 lsomeric SMILES
C1CC2=C(C=CC=C2F)/C(=N/O)/C1
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病